Overview

Treatment of Elderly Patients (>65 Years) With Acute Lymphoblastic Leukemia

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to test feasibility and efficacy of a dose reduced chemotherapy in elderly patients with newly diagnosed acute lymphoblastic leukemia. The regimen consists of induction phase I and II followed by cyclic consolidation cycles, reinduction and maintenance therapy
Phase:
Phase 4
Details
Lead Sponsor:
Johann Wolfgang Goethe University Hospital
Treatments:
6-Mercaptopurine
Cyclophosphamide
Cytarabine
Dexamethasone
Doxorubicin
Idarubicin
Ifosfamide
Mercaptopurine
Methotrexate
Vincristine